On the recordMay 10, 2016
Mr. Speaker, I rise today to bring attention to the research that the Select Investigative Panel on Infant Lives is conducting. I encourage everyone to examine the exhibits from the Select Investigative Panel on Infant Lives' investigation on their Web site: energycommerce.house.gov/select-investigative-panel. On April 20, 2016, Chairman Marsha Blackburn held a hearing on the ``Pricing of Fetal Tissue'' and found broad consensus among witnesses that Federal law may have been violated when abortion clinics profited from the sale of baby body parts. This grave circumstance has caused considerable concern because one of the underpinnings and so-called safeguards of the statute that allowed for the donation of fetal tissue for transplantation and research was that this tissue would not be sold. The author of the statute, former Congressman Henry Waxman, stated during floor debate in 1993: This amendment would enact the most important safeguards to prevent any sale of fetal issue for any purpose, not just the purpose of research. It would be abhorrent to allow for a sale of fetal tissue and a market to be created for that sale. Yet this is what is happening today. As seen on Exhibit B2, the ``Procurement Business''--the name is redacted--markets itself in its brochure as a way for clinics to make additional income by allowing procurement business technicians to collect fetal tissue and organs from aborted babies immediately after an abortion is completed.…





